Lead Product(s) : Paracetamol
Therapeutic Area : Undisclosed
Study Phase : Phase IV
Recipient : Hospital for Special Surgery, New York
Deal Size : Inapplicable
Deal Type : Inapplicable
IV vs Oral Acetaminophen in Spine Fusion Perioperative Care
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 13, 2017
Lead Product(s) : Paracetamol
Therapeutic Area : Undisclosed
Highest Development Status : Phase IV
Recipient : Hospital for Special Surgery, New York
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lubiprostone
Therapeutic Area : Undisclosed
Study Phase : Phase III
Sponsor : Takeda Pharmaceutical
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 05, 2017
Lead Product(s) : Lubiprostone
Therapeutic Area : Undisclosed
Highest Development Status : Phase III
Sponsor : Takeda Pharmaceutical
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Oxycodone Hydrochloride
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Single-Dose PK Study of an Oxycodone/Acetaminophen Solution in Healthy Subjects
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 17, 2016
Lead Product(s) : Oxycodone Hydrochloride
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Paracetamol
Therapeutic Area : Undisclosed
Study Phase : Phase IV
Recipient : Rutgers, The State University of New Jersey
Deal Size : Inapplicable
Deal Type : Inapplicable
Multi-dose Acetaminophen for Patients Undergoing General Anesthesia
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 14, 2016
Lead Product(s) : Paracetamol
Therapeutic Area : Undisclosed
Highest Development Status : Phase IV
Recipient : Rutgers, The State University of New Jersey
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : COV155
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
September 28, 2015
Lead Product(s) : COV155
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : COV155
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
September 28, 2015
Lead Product(s) : COV155
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Paracetamol
Therapeutic Area : Undisclosed
Study Phase : Phase IV
Recipient : Endeavor Health
Deal Size : Inapplicable
Deal Type : Inapplicable
The Efficacy of Intravenous Acetaminophen During Perioperative Neurosurgery Period
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 03, 2012
Lead Product(s) : Paracetamol
Therapeutic Area : Undisclosed
Highest Development Status : Phase IV
Recipient : Endeavor Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Paracetamol
Therapeutic Area : Undisclosed
Study Phase : Phase II
Recipient : Swedish Medical Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Intravenous Acetaminophen for Craniotomy Patients
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 18, 2011
Lead Product(s) : Paracetamol
Therapeutic Area : Undisclosed
Highest Development Status : Phase II
Recipient : Swedish Medical Center
Deal Size : Inapplicable
Deal Type : Inapplicable